Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00227110
Recruitment Status : Completed
First Posted : September 27, 2005
Last Update Posted : October 14, 2009
National Institutes of Health (NIH)
Takeda Pharmaceuticals North America, Inc.
Information provided by:
The University of Texas Health Science Center at San Antonio

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2005
  Actual Study Completion Date : January 2006
Publications of Results:
Other Publications: